Recognition and resistance in TEM beta-lactamase

scientific article

Recognition and resistance in TEM beta-lactamase is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/BI034242Y
P698PubMed publication ID12859188
P5875ResearchGate publication ID10663455

P50authorGeorge MinasovQ28358275
Fabio PratiQ56868569
Emilia CaselliQ56868608
Jesus BlazquezQ68273789
P2093author name stringBrian K Shoichet
Xiaojun Wang
P2860cites workCrystallography & NMR System: A New Software Suite for Macromolecular Structure DeterminationQ26778405
P433issue28
P407language of work or nameEnglishQ1860
P304page(s)8434-8444
P577publication date2003-07-01
P1433published inBiochemistryQ764876
P1476titleRecognition and resistance in TEM beta-lactamase
P478volume42

Reverse relations

cites work (P2860)
Q34680304Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii
Q35671797Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors
Q57024885Computational analysis of the interactions of a novel cephalosporin derivative with β-lactamases
Q27673054Crystal Structure of a Preacylation Complex of the β-Lactamase Inhibitor Sulbactam Bound to a Sulfenamide Bond-Containing Thiol-β-lactamase
Q56896871Engineering allosteric regulation into the hinge region of a circularly permuted TEM-1 beta-lactamase
Q33601560Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
Q35014136Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase
Q27674310Fragment-guided design of subnanomolar  -lactamase inhibitors active in vivo
Q33606363Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design
Q42173413Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases
Q47116120Label-free fiber optic optrode for the detection of class C β-lactamases expressed by drug resistant bacteria.
Q42053263Molecular dynamics of class A β-lactamases-effects of substrate binding
Q43684255Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance
Q46074569Protein promiscuity: drug resistance and native functions--HIV-1 case
Q38958278Recent Advances in the Rational Design and Optimization of Antibacterial Agents
Q35215422Role of Asp104 in the SHV beta-lactamase
Q45028104Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 beta-lactamase
Q34335278Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases
Q36134510Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
Q27684016Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative
Q36449603The continuing challenge of ESBLs
Q24646623Three decades of beta-lactamase inhibitors
Q35758823Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases

Search more.